The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
320 jobs Number of planned job losses
Announcement Date
11 July 2003
Employment effect (start)
1 July 2003
Foreseen end date
1 June 2006
Description
Merck Santé, subsidiary of Merck KGaA, announced a restructuring programme for its production and research and development (R&D) units in France. 320 jobs are affected at the Lacassagne (Lyon) unit. Half of the R&D department will be closed by the end of 2004 and half of the production department will be closed by mid-2006. Production will be transfered to the unit of Semoy (Loiret) and in Spain.
The idea of the restructuring plan comes from two studies: 'Ipso' and 'Everest' from Boston Consulting Group and Accenture.
Sources
11 July 2003: Les Echos
Citation
Eurofound (2003), Merck santé, Internal restructuring in France, factsheet number 59300, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/59300.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
